Eiger Gets Deal With Merck Over $46M Rare-Disease Drug Sale

By Alex Wittenberg · May 1, 2024, 7:21 PM EDT

Bankrupt Eiger BioPharmaceuticals Inc. told a Texas federal judge Wednesday it had struck a tentative agreement with drug company Merck & Co. over licensing rights to a rare-disease drug that it...

To view the full article, register now.

Bankruptcy Scorecard


Eiger BioPharmaceuticals Inc. filed for Chapter 11 protection in Texas bankruptcy court with $53.1 million of debt and plans to sell its assets during the case.

Case Number



Stacey Jernigan


U.S. Bankruptcy Court for the Northern District of Texas

Capital Structure

Total Liabilities:

$53.1 million

View Full Scorecard

Case Information

Case Title

Eiger BioPharmaceuticals, Inc.

Case Number



Texas Northern

Nature of Suit

Date Filed

April 01, 2024